NEW YORK ( TheStreet) -- "Things are better this time around," Jim Cramer told his "Mad Money" TV show viewers on Wednesday, as he attempted to explain why $4 a gallon gasoline hasn't begun crippling the stock market. Cramer said he could take the easy way out and just say that high gas prices haven't hit the economy yet, but that would put him in the same camp as the perma-bears who have been predicting the market's demise ever since the lows of 2008. In reality, Cramer said that if high gas really was hurting the economy, then discretionary stocks like Nike ( NKE), Lululemon Athletica ( LULU) and Harley Davidson ( HOG) wouldn't keep heading higher. "Do we really need $150 sneakers?" he asked. Cramer listed five reasons why the markets aren't being affected by the pain at the pump. First, the economy is growing. Cramer said that hiring can conquer all, even expensive gas. Second, he said unlike 2008, interest rates are low, allowing business and consumers to refinance their mortgages and debts to offset higher gas. Third, Cramer noted that gas isn't our only energy bill, and thanks to a warm winter and falling natural gas prices, the pain at the pump isn't as bad this time around. Fourth, Cramer said that companies are ready this time around and some, like Honeywell ( HON), Eaton ( ETN) and Boeing ( BA) all benefit from helping companies save on energy and fuel costs, which is why he owns the latter two for his charitable trust,
Electronic Healthcare TrendIn the "Executive Decision" segment, Cramer spoke with Glen Tullman, CEO of Allscripts Healthcare Solutions ( MDRX), a stock that's up 135% since Cramer first got behind the company in January 2009, but also one that fell short on its most recent earnings release. Tullman clarified that Allscripts did update its guidance throughout the year and did deliver on its updated projections. He said that bookings were up 26% and the company delivered strong financial results and steady, consistent growth. Tullman also noted that while the adoption of electronic healthcare records doubled last year, there are still more than half of all smaller practices that have yet to upgrade. Tullman also touted Allscripts' deal with CVS Caremark ( CVS) to bring electronic records to the chain's Minute Clinics. He said that more and more healthcare is moving away from hospitals, and CVS responded to Allscripts' unique, open system that allows the company to add new applications as they growth with the system. Turning to the larger picture, Tullman explained that as electronic records grows in adoption, they will evolve from merely accounting systems into information systems, ones that allow providers to have real-time analytics and insights that will produce better outcomes for patients. Cramer said that while Allscripts may not be growing as fast as some projected, it's clear that the company still has a lot of growth ahead of it. He reiterated his recommendation.
Riding Global TrendsIn his second "Executive Decision" segment, Cramer once again spoke with Michael Johnson, chairman and CEO of Herbalife ( HLF), which delivered a stellar 14-cent-a-share earnings beat on a 19% rise in revenues. Herbalife also raised its 2012 guidance and boosted its dividend by 50%. Shares of Herbalife are up 225% since Cramer first recommended the company in November 2009. Johnson characterized Herbalife as being at the intersection of two global trends, obesity and underemployment. He said unlike other direct marketing companies, Herbalife is different in that it brings a social, personal element to its products and offers an un-pressured environment for customers to obtain great, healthy products. Speaking of products, Johnson said that Herbalife's products are unlike any other, and the company spends heavily on product development and even grows their own crops to ensure quality. "There's really nothing else like it," Johnson explained. Turning to sales trends, Johnson said that emerging markets such as like India and China are experiencing a sales surge as customers begin to adopt a daily consumption model for Herbalife products. Once that occurs, he noted, the company will have a lot to talk about. Johnson had similarly bullish things to say about the company's expansion into Central and South America. He said starting with Mexico, sales and excitement for Herbalife has been unprecedented. Cramer called Johnson a money-maker for investors and continued his recommendation of Herbalife.